Breaking News: FDA MedWatch – Testosterone and Other Anabolic Androgenic Steroids (AAS): FDA Statement – Risks Associated With Abuse and Dependence
Today the FDA has issued a statement giving approval for
“class-wide labeling changes for all prescription testosterone products, adding a new Warning and updating the Abuse and Dependence section to include new safety information from published literature and case reports regarding the risks associated with abuse and dependence of testosterone and other AAS.” FDA Safety Alert
« Therapist are seeing Testosterone related issues in their practices…. (Previous News)
We Need You!
We Need You! Science is working diligently on the psychological and psychiatric effects of testosteroneRead More
Congress has approved the $6 billion public health initiative
This week, President Obama signed into law the 21st Century Cures Act. Congress has approvedRead More